clinical trial · NCT00764751
Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
LEO Pharma·phase2·completed·n = 51
Psoriasis VulgarisLEO 19123 Cream (calcipotriol plus LEO 80122)Dovonex® creamCream vehicle
brief summary
This study will compare the efficacy and safety of once daily treatment of LEO 19123 cream versus Dovonex® cream (applied twice daily) and versus LEO 19123 cream vehicle alone (applied twice daily) in subjects with psoriasis vulgaris. Subject will be treated for 4 weeks. All subjects will apply LEO 19123 cream to psoriasis lesions on the left or right side of the body and either Dovonex® cream or cream vehicle to lesions on the other side.
started
Sep 1, 2008
primary completion
Dec 1, 2008
completion
Jan 1, 2009
last updated
Mar 7, 2025
official title
LEO 19123 Cream in the Treatment of Psoriasis Vulgaris
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol